10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2017 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Net product sales | $ 19,258 | 17,702 | 14,045 |
| Alliance and other revenues | 1,518 | 1,725 | 2,515 |
| Total Revenues | 20,776 | 19,427 | 16,560 |
| Cost of products sold | 6,066 | 4,946 | 3,909 |
| Marketing, selling and administrative | 4,687 | 4,911 | 4,841 |
| Research and development | 6,411 | 4,940 | 5,920 |
| Other income (net) | (1,519) | (1,285) | (187) |
| Total Expenses | 15,645 | 13,512 | 14,483 |
| Earnings Before Income Taxes | 5,131 | 5,915 | 2,077 |
| Provision for Income Taxes | 4,156 | 1,408 | 446 |
| Net Earnings | 975 | 4,507 | 1,631 |
| Net Income (Loss) Attributable to Noncontrolling Interest | (32) | 50 | 66 |
| Net Earnings Attributable to BMS | 1,007 | 4,457 | 1,565 |
| Earnings per Common Share | |||
| Basic Earnings Per Common Share Attributable to BMS | 0.61 | 2.67 | 0.94 |
| Diluted Earnings per Common Share Attributable to BMS | 0.61 | 2.65 | 0.93 |
| Cash dividends declared per common share | 1.57 | 1.53 | 1.49 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2017 | |||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] | |||
| Net Earnings | $ 975 | 4,507 | 1,631 |
| Other Comprehensive Income (Loss), net of taxes and reclassifications to earnings [Abstract] | |||
| Derivatives qualifying as cash flow hedges | (57) | 4 | (51) |
| Pension and postretirement benefits | 214 | (17) | 101 |
| Available-for-sale securities | 39 | 16 | (54) |
| Foreign currency translation | 18 | (38) | (39) |
| Total Other Comprehensive Income/(Loss) | 214 | (35) | (43) |
| Comprehensive Income | 1,189 | 4,472 | 1,588 |
| Comprehensive Income Attributable to Noncontrolling Interest | (32) | 50 | 66 |
| Comprehensive Income Attributable to BMS | 1,221 | 4,422 | 1,522 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2017 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings | $ 975 | 4,507 | 1,631 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Depreciation and amortization, net | 789 | 382 | 376 |
| Deferred income taxes | 1,010 | (204) | (347) |
| Stock-based compensation | 199 | 205 | 235 |
| Impairment charges | 332 | 108 | 192 |
| Pension settlements and amortization | 236 | 169 | 245 |
| Divestiture gains and royalties | (706) | (1,187) | (490) |
| Asset acquisition charges | 760 | 274 | 983 |
| Other adjustments | 92 | (44) | 15 |
| Changes in operating assets and liabilities: | |||
| Receivables | (431) | (803) | (942) |
| Inventories | (29) | (152) | 97 |
| Accounts payable | 320 | 104 | (919) |
| Deferred income | (642) | (64) | 218 |
| Income taxes payable | 2,597 | (453) | 194 |
| Other | (227) | 216 | 617 |
| Net Cash Provided by Operating Activities | 5,275 | 3,058 | 2,105 |
| Cash Flows From Investing Activities: | |||
| Sale and maturities of marketable securities | 6,412 | 4,809 | 2,794 |
| Purchase of marketable securities | (5,437) | (3,089) | (3,143) |
| Capital expenditures | (1,055) | (1,215) | (820) |
| Divestiture and other proceeds | 722 | 1,334 | 708 |
| Acquisition and other payments | (708) | (359) | (1,111) |
| Net Cash Provided by/(Used in) Investing Activities | (66) | 1,480 | (1,572) |
| Cash Flows From Financing Activities: | |||
| Short-term borrowings, net | 727 | 125 | (449) |
| Issuance of long-term debt | 1,488 | 1,268 | |
| Repayment of long-term debt | (1,224) | (15) | (1,957) |
| Repurchase of common stock | (2,469) | (231) | |
| Dividends | (2,577) | (2,547) | (2,477) |
| Other | (22) | 15 | (9) |
| Net Cash Used in Financing Activities | (4,077) | (2,653) | (3,624) |
| Effect of Exchange Rates on Cash and Cash Equivalents | 52 | (33) | (95) |
| Increase/(Decrease) in Cash and Cash Equivalents | 1,184 | 1,852 | (3,186) |
| Cash and Cash Equivalents at Beginning of Year | 4,237 | 2,385 | |
| Cash and Cash Equivalents at End of Year | 5,421 | 4,237 | 2,385 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2017 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 13, 2018) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 5,421 | 4,237 |
| Marketable securities, current | 1,391 | 2,113 |
| Receivables | 6,300 | 5,543 |
| Inventories | 1,166 | 1,241 |
| Prepaid expenses and other | 576 | 570 |
| Total Current Assets | 14,854 | 13,704 |
| Property, plant and equipment | 5,001 | 4,980 |
| Goodwill | 6,863 | 6,875 |
| Other intangible assets | 1,210 | 1,385 |
| Deferred income taxes | 1,610 | 2,996 |
| Marketable securities, noncurrent | 2,480 | 2,719 |
| Other assets | 1,533 | 1,048 |
| Total Assets | 33,551 | 33,707 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term debt obligations | 987 | 992 |
| Accounts payable | 2,248 | 1,664 |
| Accrued liabilities | 6,014 | 5,271 |
| Deferred income, current | 83 | 762 |
| Income taxes payable, current | 231 | 152 |
| Total Current Liabilities | 9,563 | 8,841 |
| Deferred income, noncurrent | 454 | 547 |
| Income taxes payable, noncurrent | 3,548 | 973 |
| Pension and other liabilities | 1,164 | 1,283 |
| Long-term debt | 6,975 | 5,716 |
| Total Liabilities | 21,704 | 17,360 |
| Commitments and contingencies | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 4,070 in 2017 and 4,129 in 2016, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2017 and 2016 | 221 | 221 |
| Capital in excess of par value of stock | 1,898 | 1,725 |
| Accumulated other comprehensive loss | (2,289) | (2,503) |
| Retained earnings | 31,160 | 33,513 |
| Less cost of treasury stock - 575 million common shares in 2017 and 536 million in 2016 | (19,249) | (16,779) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 11,741 | 16,177 |
| Noncontrolling interest | 106 | 170 |
| Total Equity | 11,847 | 16,347 |
| Total Liabilities and Equity | 33,551 | 33,707 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |